Adalimumab Dose Reduction Aiming Low Serum Concentration With Control of Disease Activity
Clinical trial NCT04222920 · COMPLETED
Trial details
- NCT number
- NCT04222920
- Sponsor
- Reade Rheumatology Research Institute
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-01
- Primary completion
- 2023-09-11
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.